TickerFacts.

Aclarion, Inc. (ACON): Capital Expenditures

Annual figures by period end, from SEC filings.

$21.5K
Year ended 2025-12-31
2023-12-31: $02024-12-31: $5.1K2025-12-31: $21.5K$21.5K
2023-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$21.5K+320.9%2026-03-18, From 2025-01-01
2024-12-31$5.1Kn/a2026-03-18, From 2024-01-01
2023-12-31$0n/a2025-04-09, From 2023-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Aclarion, Inc. (ACON)2025-12-31$21.5K+320.9%
Sera Prognostics, Inc. (SERA)2025-12-31$726.0Kn/m
YD Bio Ltd (YDES)2025-12-31$1.44Mn/m
BioNexus Gene Lab Corp (BGLC)2025-12-31$37.0K-83.7%
American Shared Hospital Services (AMS)2025-12-31$7.63M-3.8%
CapForce Inc. (CFOR)2025-12-31$50.0Kn/a
Exagen Inc. (XGN)2025-12-31$641.0K+24.5%
Personalis, Inc. (PSNL)2025-12-31$4.50M+181.0%
Biodesix Inc (BDSX)2025-12-31$259.0K-92.0%

Compare ACON, SERA, YDES, BGLC side by side · Screen every company in Services-Medical Laboratories ↗